-
Je něco špatně v tomto záznamu ?
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study
Y. Cho, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, MB. Gharbi, SN. Davison, M. Ghnaimat, P. Harden, H. Htay, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, V. Luyckx, B. Neuen, D....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- chronické selhání ledvin terapie MeSH
- dostupnost zdravotnických služeb * MeSH
- hodnocení výsledků péče pacientem MeSH
- hodnocení výsledků zdravotní péče MeSH
- internacionalita * MeSH
- kvalita zdravotní péče MeSH
- lékaři MeSH
- lékařská praxe - způsoby provádění * MeSH
- lidé MeSH
- náklady a analýza nákladů MeSH
- nefrologie MeSH
- nefrologové MeSH
- peritoneální dialýza * MeSH
- podíl na nákladech MeSH
- poskytování zdravotní péče MeSH
- průřezové studie MeSH
- průzkumy a dotazníky MeSH
- rozvojové země MeSH
- správní úředníci MeSH
- výdaje na zdravotnictví MeSH
- vyspělé země MeSH
- zdravotní politika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
RATIONALE & OBJECTIVE: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018. OUTCOMES: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. LIMITATIONS: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. CONCLUSIONS: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
Bhumirajanagarindra Kidney Institute Bangkok Thailand
Centre for Kidney Disease Research University of Queensland Brisbane Australia
Department of Community Health Sciences University of Calgary Calgary Alberta Canada
Department of Intensive Care Austin Health Melbourne Australia
Department of Medicine Monash University Clayton Victoria Australia
Department of Medicine The University of Hong Kong Queen Mary Hospital Hong Kong
Department of Medicine University of Calgary Calgary Alberta Canada
Department of Nephrology General University Hospital Charles University Prague Czech Republic
Department of Nephrology Kidney Foundation Hospital and Research Institute Dhaka Bangladesh
Department of Nephrology Monash Medical Centre Monash Health Clayton Victoria Australia
Department of Renal Medicine Singapore General Hospital Singapore
Dialysis Unit CASMU IAMPP Montevideo Uruguay
Division of Nephology and Hypertension Department of Medicine Saint Louis University Saint Louis MO
Division of Nephrology and Hypertension University of California Irvine Medical Center Orange CA
Division of Nephrology and Hypertension University of Cape Town Cape Town South Africa
Division of Nephrology Bezmialem Vakif University Istanbul Turkey
Division of Nephrology Department of Medicine University of Toronto Toronto Ontario Canada
George Institute for Global Health University of Oxford Oxford United Kingdom
George Institute for Global Health UNSW New Delhi India
Institute of Biomedical Ethics and the History of Medicine University of Zurich Zurich Switzerland
Key Lab of Renal Disease Ministry of Health of China Beijing China
Kidney and Hypertension Research Unit University of Cape Town Cape Town South Africa
Manipal Academy of Higher Education Manipal India
Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia
Nephrology Division Department of Internal Medicine The Specialty Hospital Amman Jordan
Oxford Kidney Unit Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom
Peking Tsinghua Center for Life Sciences Beijing China
Population Health Sciences University of Bristol Bristol United Kingdom
Renal Division Brigham and Women's Hospital Harvard Medical School Boston MA
Renal Division Department of Medicine Peking University 1st Hospital Beijing China
Renal Unit Southmead Hospital North Bristol NHS Trust Bristol United Kingdom
Salford Royal NHS Foundation Trust Salford United Kingdom
School of Medicine University of Melbourne Melbourne Australia
Sorbonne Université Paris France
Translational Research Institute Brisbane Australia
University of Leicester Leicester United Kingdom
University of Manchester Manchester United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011444
- 003
- CZ-PrNML
- 005
- 20210507101547.0
- 007
- ta
- 008
- 210420s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1053/j.ajkd.2020.05.032 $2 doi
- 035 __
- $a (PubMed)32800844
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cho, Yeoungjee $u Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia. Electronic address: yeoungjee.cho@health.qld.gov.au
- 245 10
- $a Peritoneal Dialysis Use and Practice Patterns: An International Survey Study / $c Y. Cho, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, MB. Gharbi, SN. Davison, M. Ghnaimat, P. Harden, H. Htay, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, V. Luyckx, B. Neuen, D. O'Donoghue, S. Ossareh, J. Perl, HU. Rashid, E. Rondeau, EJ. See, S. Saad, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, RT. Kazancioglu, A. Yee-Moon Wang, CW. Yang, A. Zemchenkov, MH. Zhao, KJ. Jager, FJ. Caskey, KK. Jindal, IG. Okpechi, M. Tonelli, DC. Harris, DW. Johnson
- 520 9_
- $a RATIONALE & OBJECTIVE: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. STUDY DESIGN: A cross-sectional survey. SETTING & PARTICIPANTS: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018. OUTCOMES: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures. ANALYTICAL APPROACH: Descriptive statistics. RESULTS: Responses were received from 88% (n=160) of countries and there were 313 participants (257 nephrologists [82%], 22 non-nephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n=156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/22). In 69% of countries, PD was the initial dialysis modality for≤10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. LIMITATIONS: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. CONCLUSIONS: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.
- 650 _2
- $a správní úředníci $7 D000288
- 650 _2
- $a podíl na nákladech $7 D017047
- 650 _2
- $a náklady a analýza nákladů $7 D003365
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a poskytování zdravotní péče $7 D003695
- 650 _2
- $a vyspělé země $7 D019049
- 650 _2
- $a rozvojové země $7 D003906
- 650 _2
- $a výdaje na zdravotnictví $7 D005102
- 650 _2
- $a zdravotní politika $7 D006291
- 650 12
- $a dostupnost zdravotnických služeb $7 D006297
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a internacionalita $7 D038622
- 650 _2
- $a chronické selhání ledvin $x terapie $7 D007676
- 650 _2
- $a nefrologové $7 D000072104
- 650 _2
- $a nefrologie $7 D009398
- 650 _2
- $a hodnocení výsledků zdravotní péče $7 D017063
- 650 _2
- $a hodnocení výsledků péče pacientem $7 D000071066
- 650 12
- $a peritoneální dialýza $7 D010530
- 650 _2
- $a lékaři $7 D010820
- 650 12
- $a lékařská praxe - způsoby provádění $7 D010818
- 650 _2
- $a kvalita zdravotní péče $7 D011787
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bello, Aminu K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Levin, Adeera $u Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
- 700 1_
- $a Lunney, Meaghan $u Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Osman, Mohamed A $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ye, Feng $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ashuntantang, Gloria E $u Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde I, Yaounde, Cameroon
- 700 1_
- $a Bellorin-Font, Ezequiel $u Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, MO
- 700 1_
- $a Gharbi, Mohammed Benghanem $u Urinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco
- 700 1_
- $a Davison, Sara N $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Ghnaimat, Mohammad $u Nephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan
- 700 1_
- $a Harden, Paul $u Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 700 1_
- $a Htay, Htay $u Department of Renal Medicine, Singapore General Hospital, Singapore
- 700 1_
- $a Jha, Vivekanand $u George Institute for Global Health, UNSW, New Delhi, India; George Institute for Global Health, University of Oxford, Oxford, United Kingdom; Manipal Academy of Higher Education, Manipal, India
- 700 1_
- $a Kalantar-Zadeh, Kamyar $u Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA
- 700 1_
- $a Kerr, Peter G $u Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia
- 700 1_
- $a Klarenbach, Scott $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Kovesdy, Csaba P $u University of Tennessee Health Science Center, Memphis, TN
- 700 1_
- $a Luyckx, Valerie $u Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
- 700 1_
- $a Neuen, Brendon $u George Institute for Global Health, UNSW, New Delhi, India
- 700 1_
- $a O'Donoghue, Donal $u Salford Royal NHS Foundation Trust, Salford, United Kingdom; University of Manchester, Manchester, United Kingdom
- 700 1_
- $a Ossareh, Shahrzad $u Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Perl, Jeffrey $u Division of Nephrology, St. Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 700 1_
- $a Rashid, Harun Ur $u Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh
- 700 1_
- $a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France; Sorbonne Université, Paris, France
- 700 1_
- $a See, Emily J $u Department of Intensive Care, Austin Health, Melbourne, Australia; School of Medicine, University of Melbourne, Melbourne, Australia
- 700 1_
- $a Saad, Syed $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Sola, Laura $u Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay
- 700 1_
- $a Tchokhonelidze, Irma $u Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Tungsanga, Kriang $u Department of Medicine, Faculty of Medicine, King Chulalong Memorial Hospital, Chulalongkorn University, Bangkok, Thailand; Bhumirajanagarindra Kidney Institute, Bangkok, Thailand
- 700 1_
- $a Kazancioglu, Rumeyza Turan $u Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey
- 700 1_
- $a Yee-Moon Wang, Angela $u Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
- 700 1_
- $a Yang, Chih-Wei $u Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
- 700 1_
- $a Zemchenkov, Alexander $u Department of Internal Disease and Nephrology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg, Russia; Department of Nephrology and Dialysis, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
- 700 1_
- $a Zhao, Ming-Hui $u Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China; Key Lab of Renal Disease, Ministry of Health of China, Beijing, China; Key Lab of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China; Peking-Tsinghua Center for Life Sciences (CLS), Beijing, China
- 700 1_
- $a Jager, Kitty J $u ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Caskey, Fergus J $u Population Health Sciences, University of Bristol, Bristol, United Kingdom; Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom
- 700 1_
- $a Jindal, Kailash K $u Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa
- 700 1_
- $a Okpechi, Ikechi G $u Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Calgary, Calgary, Alberta, Canada
- 700 1_
- $a Tonelli, Marcello $u Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, Alberta, Canada; University of Leicester, Leicester, United Kingdom
- 700 1_
- $a Harris, David C $u Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Johnson, David W $u Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia
- 773 0_
- $w MED00000258 $t American journal of kidney diseases : the official journal of the National Kidney Foundation $x 1523-6838 $g Roč. 77, č. 3 (2021), s. 315-325
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32800844 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507101547 $b ABA008
- 999 __
- $a ok $b bmc $g 1649970 $s 1131823
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 77 $c 3 $d 315-325 $e 20200812 $i 1523-6838 $m American journal of kidney diseases $n Am J Kidney Dis $x MED00000258
- LZP __
- $a Pubmed-20210420
